Paraveganio was developed by Axunio, a German pharmaceutical business, and includes entirely plant-based components. It is the first product to get vegan certification from The Vegan Society.
“By completely dispensing with animal additives, we guarantee a 100 percent vegan drug, and have also had this officially certified by The Vegan Society – as the very first pharmaceutical company in the world!” states Axunio on its website.
While paracetamol is one of the most widely used over-the-counter pain relievers, many people are unaware that most paracetamol products include magnesium stearate, an animal-derived ingredient.
Magnesium stearate, the magnesium salt of stearic acid, is widely utilized in the pharmaceutical sector for its lubricating characteristics in tablets and capsules. Stearic acid is a kind of fatty acid that is mainly generated from animal fats.
Paraveganio includes magnesium stearate extracted from 100% vegetable origin rather than animal-based magnesium stearate.
The paracetamol-based pain reliever is certified vegan and includes 500mg of the active component paracetamol. It can also be used to treat fevers and reduce mild to moderate pain, exactly like other paracetamol medicines.
According to The Vegan Society, animal-based components are included in almost 75% of the most regularly prescribed medications in the UK. Many more, of course, are subjected to animal testing before being approved for use.
“With the launch of our first vegan-certified drug, we want to initiate a long-term rethink in the pharmaceutical industry,” stated Julia von Horsten, product and business development manager for Axunio.
The Vegan Society has reached a watershed point with the vegan certification.
For many years, the Vegan Society has advocated for the development of animal-free pharmaceuticals. Its 2017 campaign “Make More Medicines Vegan” petitioned the UK government to create more vegan options for the rising vegan population.
“We’re delighted to see our Vegan Trademark for the first time on a vegan medicinal product. We know that many vegans struggle to find a medication that is both suitable to their needs and in line with their beliefs, which can be distressing,” stated Ericka Durgahee, marketing manager at The Vegan Society, in a press statement.
Available in Germany
While Paraveganio tablets are now only accessible in Germany, Axunio aims to extend to other regions soon. Visit Axunio for more information on the vegan-friendly product.
vKind is the U.S.’s largest fully-vegan search platform and listing app. Give our search tool a whirl and find any vegan product, service, or experience you desire.
HOW TO GET INVOLVED
LEARN ABOUT PEELED, OUR BRAND NEW TV SHOW: VKind is making VEGAN HISTORY by introducing the first and only 100% vegan cooking competition TV show! Be sure to visit our new Peeled website for the latest news, contests, giveaways, and raffles and to get VIP tickets to our Worldwide Premiere on Sept. 24th, 2022! Our exclusive red carpet premiere event will be held in the prestigious Directors Guild of America Theater in Hollywood, CA. Visit PeeledShow.Com now to learn more!
CONTESTS & GIVEAWAYS: Be the first to hear about our latest Giveaways, Contests, and Raffles by following us on Instagram where all of our giveaways are featured.
WATCH & LEARN: We have so much exciting content on our YouTube channel with some amazing new shows! Subscribe to our YouTube channel for our latest shows, live events, interviews, videos, news, secret giveaway contests & more!
GET FEATURED: We would love to publish & promote your delicious vegan recipes on our App, websites, and social media channels. Submit your recipes here!
ADD YOUR LISTING: Are you ready to attract customers and clients hyped on your values and what you offer? We’re all about opening up more possibilities to support small to medium-sized vegan businesses, professionals, and companies, like YOU. Add your listing now!
SUBSCRIBE FOR THE LATEST NEWS: Get exclusive access to the latest vegan businesses, events, and plant-based news hot off the press. Subscribe to our Newsletter.